Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Sell
13
INBS Quote, Financials, Valuation and Earnings
Last price:
$1.28
Seasonality move
:
-26.37%
Day range:
$1.18 - $1.30
52-week range:
$1.00 - $3.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.45x
P/B ratio:
1.54x
Volume:
35.6K
Avg. volume:
132.8K
1-year change:
-62.09%
Market cap:
$6.7M
Revenue:
$3.1M
EPS (TTM):
-$3.44
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
INBS
Intelligent Bio Solutions
|
$1.4M | -- | 160.36% | -- | -- |
|
AIMD
Ainos
|
-- | -- | -- | -- | -- |
|
HSIC
Henry Schein
|
$3.2B | $1.11 | 2.15% | 57.25% | $77.85 |
|
LAB
Standard BioTools
|
$40.1M | -$0.04 | -11.95% | -85.19% | $2.38 |
|
LNSR
LENSAR
|
$13.4M | -$0.16 | 26.61% | -18.42% | $15.00 |
|
PDCO
Patterson Companies
|
$1.6B | $0.62 | 0.97% | 20.34% | $30.42 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
INBS
Intelligent Bio Solutions
|
$1.27 | -- | $6.7M | -- | $0.00 | 0% | 1.45x |
|
AIMD
Ainos
|
$0.64 | -- | $9.9M | -- | $0.00 | 0% | 66.61x |
|
HSIC
Henry Schein
|
$64.46 | $77.85 | $8B | 21.20x | $0.00 | 0% | 0.65x |
|
LAB
Standard BioTools
|
$1.15 | $2.38 | $435.8M | -- | $0.00 | 0% | 2.33x |
|
LNSR
LENSAR
|
$13.49 | $15.00 | $159M | -- | $0.00 | 0% | 2.90x |
|
PDCO
Patterson Companies
|
$30.91 | $30.42 | $2.7B | 20.07x | $0.26 | 3.37% | 0.42x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
INBS
Intelligent Bio Solutions
|
8.5% | 3.316 | 6.18% | 0.66x |
|
AIMD
Ainos
|
20.03% | 0.902 | 81.11% | 0.22x |
|
HSIC
Henry Schein
|
42.77% | 1.394 | 25.27% | 0.57x |
|
LAB
Standard BioTools
|
0.06% | -0.266 | 0.05% | 4.95x |
|
LNSR
LENSAR
|
-- | 1.860 | -- | 1.93x |
|
PDCO
Patterson Companies
|
43.14% | -0.906 | 27.42% | 0.46x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
INBS
Intelligent Bio Solutions
|
$223.1K | -$2.3M | -152.69% | -164.63% | -369.27% | -$2.3M |
|
AIMD
Ainos
|
$80 | -$4.6M | -45.16% | -52.95% | -15756.26% | -$865.1K |
|
HSIC
Henry Schein
|
$993M | $192M | 5.21% | 7.8% | 5.05% | $159M |
|
LAB
Standard BioTools
|
$21.9M | -$29.7M | -32.61% | -36.54% | -64.16% | -$17.4M |
|
LNSR
LENSAR
|
$7.1M | -$1.3M | -134.77% | -134.77% | -7.71% | $3.7M |
|
PDCO
Patterson Companies
|
$320.8M | $45.4M | 8.16% | 14.22% | 3.41% | -$296.6M |
Intelligent Bio Solutions vs. Competitors
-
Which has Higher Returns INBS or AIMD?
Ainos has a net margin of -370.29% compared to Intelligent Bio Solutions's net margin of -15991.17%. Intelligent Bio Solutions's return on equity of -164.63% beat Ainos's return on equity of -52.95%.
Company Gross Margin Earnings Per Share Invested Capital INBSIntelligent Bio Solutions36.73% -$0.50 $4.6M AIMDAinos-29.07% -$0.30 $28.4M -
What do Analysts Say About INBS or AIMD?
Intelligent Bio Solutions has a consensus price target of --, signalling upside risk potential of 844.88%. On the other hand Ainos has an analysts' consensus of -- which suggests that it could fall by --. Given that Intelligent Bio Solutions has higher upside potential than Ainos, analysts believe Intelligent Bio Solutions is more attractive than Ainos.
Company Buy Ratings Hold Ratings Sell Ratings INBSIntelligent Bio Solutions0 0 0 AIMDAinos0 0 0 -
Is INBS or AIMD More Risky?
Intelligent Bio Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ainos has a beta of 1.832, suggesting its more volatile than the S&P 500 by 83.213%.
-
Which is a Better Dividend Stock INBS or AIMD?
Intelligent Bio Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ainos offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intelligent Bio Solutions pays -- of its earnings as a dividend. Ainos pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INBS or AIMD?
Intelligent Bio Solutions quarterly revenues are $607.5K, which are larger than Ainos quarterly revenues of $20.7K. Intelligent Bio Solutions's net income of -$2.2M is higher than Ainos's net income of -$4.7M. Notably, Intelligent Bio Solutions's price-to-earnings ratio is -- while Ainos's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intelligent Bio Solutions is 1.45x versus 66.61x for Ainos. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INBSIntelligent Bio Solutions1.45x -- $607.5K -$2.2M AIMDAinos66.61x -- $20.7K -$4.7M
-
Which has Higher Returns INBS or HSIC?
Henry Schein has a net margin of -370.29% compared to Intelligent Bio Solutions's net margin of 2.95%. Intelligent Bio Solutions's return on equity of -164.63% beat Henry Schein's return on equity of 7.8%.
Company Gross Margin Earnings Per Share Invested Capital INBSIntelligent Bio Solutions36.73% -$0.50 $4.6M HSICHenry Schein31.12% $0.74 $7.4B -
What do Analysts Say About INBS or HSIC?
Intelligent Bio Solutions has a consensus price target of --, signalling upside risk potential of 844.88%. On the other hand Henry Schein has an analysts' consensus of $77.85 which suggests that it could grow by 20.77%. Given that Intelligent Bio Solutions has higher upside potential than Henry Schein, analysts believe Intelligent Bio Solutions is more attractive than Henry Schein.
Company Buy Ratings Hold Ratings Sell Ratings INBSIntelligent Bio Solutions0 0 0 HSICHenry Schein3 8 1 -
Is INBS or HSIC More Risky?
Intelligent Bio Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Henry Schein has a beta of 0.844, suggesting its less volatile than the S&P 500 by 15.587%.
-
Which is a Better Dividend Stock INBS or HSIC?
Intelligent Bio Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Henry Schein offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intelligent Bio Solutions pays -- of its earnings as a dividend. Henry Schein pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INBS or HSIC?
Intelligent Bio Solutions quarterly revenues are $607.5K, which are smaller than Henry Schein quarterly revenues of $3.2B. Intelligent Bio Solutions's net income of -$2.2M is lower than Henry Schein's net income of $94M. Notably, Intelligent Bio Solutions's price-to-earnings ratio is -- while Henry Schein's PE ratio is 21.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intelligent Bio Solutions is 1.45x versus 0.65x for Henry Schein. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INBSIntelligent Bio Solutions1.45x -- $607.5K -$2.2M HSICHenry Schein0.65x 21.20x $3.2B $94M
-
Which has Higher Returns INBS or LAB?
Standard BioTools has a net margin of -370.29% compared to Intelligent Bio Solutions's net margin of -72.93%. Intelligent Bio Solutions's return on equity of -164.63% beat Standard BioTools's return on equity of -36.54%.
Company Gross Margin Earnings Per Share Invested Capital INBSIntelligent Bio Solutions36.73% -$0.50 $4.6M LABStandard BioTools46.89% -$0.09 $472M -
What do Analysts Say About INBS or LAB?
Intelligent Bio Solutions has a consensus price target of --, signalling upside risk potential of 844.88%. On the other hand Standard BioTools has an analysts' consensus of $2.38 which suggests that it could grow by 106.52%. Given that Intelligent Bio Solutions has higher upside potential than Standard BioTools, analysts believe Intelligent Bio Solutions is more attractive than Standard BioTools.
Company Buy Ratings Hold Ratings Sell Ratings INBSIntelligent Bio Solutions0 0 0 LABStandard BioTools2 1 0 -
Is INBS or LAB More Risky?
Intelligent Bio Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Standard BioTools has a beta of 1.541, suggesting its more volatile than the S&P 500 by 54.101%.
-
Which is a Better Dividend Stock INBS or LAB?
Intelligent Bio Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intelligent Bio Solutions pays -- of its earnings as a dividend. Standard BioTools pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INBS or LAB?
Intelligent Bio Solutions quarterly revenues are $607.5K, which are smaller than Standard BioTools quarterly revenues of $46.7M. Intelligent Bio Solutions's net income of -$2.2M is higher than Standard BioTools's net income of -$34.1M. Notably, Intelligent Bio Solutions's price-to-earnings ratio is -- while Standard BioTools's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intelligent Bio Solutions is 1.45x versus 2.33x for Standard BioTools. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INBSIntelligent Bio Solutions1.45x -- $607.5K -$2.2M LABStandard BioTools2.33x -- $46.7M -$34.1M
-
Which has Higher Returns INBS or LNSR?
LENSAR has a net margin of -370.29% compared to Intelligent Bio Solutions's net margin of -111.78%. Intelligent Bio Solutions's return on equity of -164.63% beat LENSAR's return on equity of -134.77%.
Company Gross Margin Earnings Per Share Invested Capital INBSIntelligent Bio Solutions36.73% -$0.50 $4.6M LNSRLENSAR42.48% -$1.61 $4.9M -
What do Analysts Say About INBS or LNSR?
Intelligent Bio Solutions has a consensus price target of --, signalling upside risk potential of 844.88%. On the other hand LENSAR has an analysts' consensus of $15.00 which suggests that it could grow by 11.19%. Given that Intelligent Bio Solutions has higher upside potential than LENSAR, analysts believe Intelligent Bio Solutions is more attractive than LENSAR.
Company Buy Ratings Hold Ratings Sell Ratings INBSIntelligent Bio Solutions0 0 0 LNSRLENSAR0 2 0 -
Is INBS or LNSR More Risky?
Intelligent Bio Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LENSAR has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock INBS or LNSR?
Intelligent Bio Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intelligent Bio Solutions pays -- of its earnings as a dividend. LENSAR pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INBS or LNSR?
Intelligent Bio Solutions quarterly revenues are $607.5K, which are smaller than LENSAR quarterly revenues of $16.7M. Intelligent Bio Solutions's net income of -$2.2M is higher than LENSAR's net income of -$18.7M. Notably, Intelligent Bio Solutions's price-to-earnings ratio is -- while LENSAR's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intelligent Bio Solutions is 1.45x versus 2.90x for LENSAR. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INBSIntelligent Bio Solutions1.45x -- $607.5K -$2.2M LNSRLENSAR2.90x -- $16.7M -$18.7M
-
Which has Higher Returns INBS or PDCO?
Patterson Companies has a net margin of -370.29% compared to Intelligent Bio Solutions's net margin of 1.99%. Intelligent Bio Solutions's return on equity of -164.63% beat Patterson Companies's return on equity of 14.22%.
Company Gross Margin Earnings Per Share Invested Capital INBSIntelligent Bio Solutions36.73% -$0.50 $4.6M PDCOPatterson Companies20.4% $0.35 $1.7B -
What do Analysts Say About INBS or PDCO?
Intelligent Bio Solutions has a consensus price target of --, signalling upside risk potential of 844.88%. On the other hand Patterson Companies has an analysts' consensus of $30.42 which suggests that it could fall by -1.6%. Given that Intelligent Bio Solutions has higher upside potential than Patterson Companies, analysts believe Intelligent Bio Solutions is more attractive than Patterson Companies.
Company Buy Ratings Hold Ratings Sell Ratings INBSIntelligent Bio Solutions0 0 0 PDCOPatterson Companies0 11 0 -
Is INBS or PDCO More Risky?
Intelligent Bio Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Patterson Companies has a beta of 0.731, suggesting its less volatile than the S&P 500 by 26.948%.
-
Which is a Better Dividend Stock INBS or PDCO?
Intelligent Bio Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Patterson Companies offers a yield of 3.37% to investors and pays a quarterly dividend of $0.26 per share. Intelligent Bio Solutions pays -- of its earnings as a dividend. Patterson Companies pays out 52.89% of its earnings as a dividend. Patterson Companies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios INBS or PDCO?
Intelligent Bio Solutions quarterly revenues are $607.5K, which are smaller than Patterson Companies quarterly revenues of $1.6B. Intelligent Bio Solutions's net income of -$2.2M is lower than Patterson Companies's net income of $31.3M. Notably, Intelligent Bio Solutions's price-to-earnings ratio is -- while Patterson Companies's PE ratio is 20.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intelligent Bio Solutions is 1.45x versus 0.42x for Patterson Companies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INBSIntelligent Bio Solutions1.45x -- $607.5K -$2.2M PDCOPatterson Companies0.42x 20.07x $1.6B $31.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
What Do Tesla Delivery Numbers Mean for Tesla Stock?
Tesla (NASDAQ:TSLA) released Q1 delivery numbers, showing a substantial slowdown…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
